Results of treatment with 131 I-metaiodobenzylguanidine (131 I-MIBG) in patients with neuroblastoma. Future prospects of zetotherapy

Prog Clin Biol Res. 1991:366:439-45.

Authors

P A Voûte¹, C A Hoefnagel, J de Kraker, R Valdes Olmos, D J Bakker, A J van de Kleij

Affiliation

¹ Academic Medical Centre, Dpt. of Pediatric Oncology, the Netherlands Cancer Institute, Amsterdam.

PMID: 2068157

No abstract available

MeSH terms

3-Iodobenzylguanidine
Adult
Antineoplastic Agents / therapeutic use*
Bone Neoplasms / diagnostic imaging
Bone Neoplasms / drug therapy
Bone Neoplasms / radiotherapy
Bone Neoplasms / secondary
Child
Female
Follow-Up Studies
Humans
Iodine Radioisotopes / therapeutic use*
Iodobenzenes / adverse effects
Iodobenzenes / therapeutic use*
Male
Neuroblastoma / diagnostic imaging
Neuroblastoma / drug therapy
Neuroblastoma / radiotherapy*
Radionuclide Imaging

Substances

Antineoplastic Agents
Iodine Radioisotopes
Iodobenzenes
3-Iodobenzylguanidine